Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report.
Mele
Anna
A
Department of Haematology, Hospital San Salvatore, Pesaro, Italy.
Sparaventi
Giovanni
G
Guiducci
Barbara
B
Nicolini
Giuseppina
G
d'Adamo
Francesca
F
Leopardi
Giuliana
G
Delfini
Costante
C
Piccaluga
Pierpaolo
P
Visani
Giuseppe
G
D000368:Aged; D000617:Aminoglycosides / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D000079982:Gemtuzumab; D006801:Humans; D000922:Immunotoxins / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D016879:Salvage Therapy; D016896:Treatment Outcome
D000617:Aminoglycosides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000922:Immunotoxins; D003561:Cytarabine; D000079982:Gemtuzumab